US Bancorp’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-40
| Closed | -$144 | – | 4186 |
|
|
2022
Q4 | $144 | Hold |
40
| – | – | ﹤0.01% | 4058 |
|
|
2022
Q3 | $0 | Hold |
40
| – | – | ﹤0.01% | 4217 |
|
|
2022
Q2 | $0 | Hold |
40
| – | – | ﹤0.01% | 4237 |
|
|
2022
Q1 | $0 | Hold |
40
| – | – | ﹤0.01% | 4196 |
|
|
2021
Q4 | $1K | Sell |
40
-25
| -38% | -$625 | ﹤0.01% | 4017 |
|
|
2021
Q3 | $3K | Sell |
65
-56
| -46% | -$2.59K | ﹤0.01% | 3791 |
|
|
2021
Q2 | $7K | Buy |
121
+48
| +66% | +$2.78K | ﹤0.01% | 3517 |
|
|
2021
Q1 | $5K | Hold |
73
| – | – | ﹤0.01% | 3493 |
|
|
2020
Q4 | $8K | Buy |
73
+33
| +83% | +$3.62K | ﹤0.01% | 3256 |
|
|
2020
Q3 | $4K | Buy |
+40
| New | +$4K | ﹤0.01% | 3311 |
|
|
2018
Q4 | – | Sell |
-100
| Closed | -$12K | – | 3715 |
|
|
2018
Q3 | $12K | Hold |
100
| – | – | ﹤0.01% | 3071 |
|
|
2018
Q2 | $10K | Hold |
100
| – | – | ﹤0.01% | 3146 |
|
|
2018
Q1 | $13K | Hold |
100
| – | – | ﹤0.01% | 3085 |
|
|
2017
Q4 | $10K | Buy |
+100
| New | +$10K | ﹤0.01% | 3149 |
|